BB&T Investment Services’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

BB&T Investment Services’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$18K	Buy	+186	New	+$17.6K	﹤0.01%	833

Other funds holding LKFT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BB&T Investment Services's LKFT Position: Q4 2017 in Review

BB&T Investment Services opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2017: 186 shares worth $18K. The stake represents ﹤0.01% of the portfolio and ranks #833 among its holdings.

77 funds tracked by Wall St. Rank hold LKFT as of Q4 2017.

BB&T Investment Services held 186 shares of Lakefront Biotherapeutics American Depositary Shares worth $18K as of Q4 2017.
Lakefront Biotherapeutics American Depositary Shares was a new BB&T Investment Services position in Q4 2017.
Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of BB&T Investment Services's portfolio in Q4 2017, its #833 holding.
77 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.